GCP
ONC

GSA Capital Partners’s BeOne Medicines Ltd ONC Stock Holding History

GSA Capital Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$989K Buy
+3,330
New +$1.08M 0.06% 502
2025
Q4 		– Sell
-3,223
Closed -$1.1M – 2173
2025
Q3 		$1.1M Sell
3,223
-86
-3% -$26.1K 0.09% 348
2025
Q2 		$801K Buy
3,309
+150
+5% +$36.8K 0.06% 605
2025
Q1 		$860K Buy
+3,159
New +$739K 0.08% 441
2023
Q3 		– Sell
-1,177
Closed -$210K – 1986
2023
Q2 		$210K Buy
+1,177
New +$271K 0.02% 1238
2021
Q4 		– Sell
-1,560
Closed -$566K – 1860
2021
Q3 		$566K Buy
+1,560
New +$510K 0.06% 631

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return